Afyren
Biobased solutions for a low-carbon circular industry
Clermont-Ferrand, France · Founded 2012 · $33.0M raised
- Headquarters
- Clermont-Ferrand
- Employees
- 51–200
- Founded
- 2012
- Business Model
- B2B
- Website
- afyren.com
- Total Funding
- $33.0M
- Last Round
- $25.3M Venture RoundNov 2025
- Rounds
- 3
About
AFYREN is a French pioneering biotech company that produces 7 fully biobased organic acids and derivatives from non-food agricultural biomass through a proprietary biomimetic fermentation process, reducing the carbon footprint of conventional chemistry by a factor of five. The company operates AFYREN NEOXY, its first industrial-scale biorefinery located in Carling Saint-Avold, France, producing sustainable ingredients for food, cosmetics, pharmaceuticals, chemicals, and materials industries. Founded in 2012 and B Corp certified, AFYREN partners with international companies to replace petroleum-derived molecules with circular, low-carbon biobased alternatives in a zero-waste production model.
Summary
Afyren is a Biotech company based in Clermont-Ferrand, France, founded in 2012. It has raised $33.0M in total across 3 rounds, most recently a $25.3M Venture Round round in Nov 2025. Investors include Kemin Industries, Odyssée Venture and Bpifrance.
Tech & App Stack
5 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Nov 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Leading North American energy infrastructure platform.
Green steel company using hydrogen and renewable electricity to decarbonize steel production. For...
Self-driving cars.
China's leading blood products manufacturer

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Sustainable infrastructure finance